The Global Bone Marrow Transplantation Market Size accounted for USD 11,108 Million in 2021 and is estimated to garner a market size of USD 18,065 Million by 2030 rising at a CAGR of 5.7% from 2022 to 2030. The increasing number of cancer treatments fuels the bone marrow transplantation market share. Additionally, rising adoption of bone marrow transplantation and growing cases of anemia are also driving the market growth. Rapid technological advancements in these procedure is one of the leading bone marrow transplantation market trends that is fueling the industry share.
Bone Marrow Transplantation Market Report Key Highlights
The method of replacing disease-related or weakened bone marrow or bone marrow stem cells with healthy tissues is often referred to as hematopoietic stem cell transplantation. Bone marrow is soft vascular tissue within long bones that primarily induces the formation of blood cells, lymphocytic growth, and fat accumulation. Severe stages of leukemia, Hodgkin and non-Hodgkin Lymphomas, palatial, sickle cell anemia and thalassemia, etc. are advised for bone marrow transplantation. More than 75.000 bone marrow transplants have been performed worldwide in 2015 and are expected to increase by 25% by the end of 2020. Bone marrow transplantation is known as either peripheral stem cell transplantation (PSCT) or conventional bone marrow transplantation based on the source of the bone marrow or stem cells. High demand for BMOs and continued field work to reduce the risk of negative effects of BMO transplantation can lead to a new market peak for millions of people around the world to improve healthcare.
The report provides analysis of global bone marrow transplantation market for the period 2018 – 2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Global Bone Marrow Transplantation Market Dynamics
Bone Marrow Transplantations Market Report Coverage
|Market||Bone Marrow Transplantation Market|
|Bone Marrow Transplantation Market Size 2021||USD 11,108 Million|
|Bone Marrow Transplantation Market Forecast 2030||USD 18,065 Million|
|Bone Marrow Transplantation Market CAGR During 2022 - 2030||5.7%|
|Bone Marrow Transplantation Market Analysis Period
||2018 - 2030|
|Bone Marrow Transplantation Market Base Year||2021|
|Bone Marrow Transplantation Market Forecast Data||2022 - 2030|
|Segments Covered||By Type, By Indications, By End-User, And By Geography
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||Agendia, Merck Millipore Corporation, Sanofi, AllCells LLC, Diadexus Inc., Abbott, STEMCELL Technologies, Lonza Group Ltd., Conversant Bio, and Qiagen N.V.|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
Bone Marrow Transplantation Market Insights
The last resort usually prescribed by physicians for bone marrow and blood cancer is bone marrow transplantation. As a result, the spiraling incidence of these diseases, usually blood cancer, may be conveniently projected to be a key force driving the growth of the global bone marrow transplantation industry. Bone marrow dysfunction can be particularly harmful to the health of the human body. In this respect, an increasing need for bone marrow transplantation may be caused by the increasing ubiquity of unhealthy diets, inactive living, and alcohol and nicotine abuse.
There is a move towards climbing on the part of bone marrow transplantation, with patients being more positive about the treatment. Improving the clinical status of patients may be due to intensive study and production of bone marrow transplants. This is expected to greatly improve the success of the global bone marrow transplantation industry as the procedure continues to be unquestionable and technically advanced. Extensive work on the recruitment, processing, and logistical and biological considerations of the donated bone marrow may provide an explanation for increased efficiency.
The improved success rate for bone marrow transplantation for a potential increase in adoption
Patient survival rates following bone marrow transplantation have dramatically improved in recent years, with a significant increase in demand for bone marrow transplantation. Leukemia and other blood cancers could be the safest cure option at the end of the day. For example, FMT in the United States stated that the 1-year survival rate for the Mayo Foundation for Medical Education and Research was 73 percent for BMTs and 98 percent for BMTs in the United States
The increasing prevalence of blood cancer is driving the demand for bone marrow transplantation in emerging regions
The incidence of blood cancer has increased over the last decade. In developing countries, the incidence of blood cancer is 1.5X higher than in developed areas. Increased per capita income has contributed to a significant increase in healthcare spending in most developed regions. The total demand for bone marrow transplantation in the country is expected to increase.
Simple Access to Bone Marrow Care in the United States
Policies such as state bone marrow registries, hematopoietic cell registries for non-profit cells, state marrow donation programs, etc., have made it easy for patients to access the otherwise complicated test cycle in the US. For example, according to a study in the US, the incidence of bone marrow transplantation increased by 5% between 2009 and 2013.
Bone Marrow Transplantation Market Segmentation
The worldwide bone marrow transplantation market is split based on type, indications, end-user, and geography.
Bone Marrow Transplantation Market By Type
According to our bone marrow transplantation industry analysis, autologous bone marrow transplants will hold a significant market share in 2021. Furthermore, autologous bone marrow transplantation is likely to continue in the following years from 2022 to 2030. The first step in this sort of transplant is to extract or harvest the patient's own stem cells. Their stem cells are extracted from their bone marrow or blood and frozen. One benefit of autologous stem cell transplant is that the patient receives his or her own cells.
Bone Marrow Transplantation Market By Indications
According to the bone marrow transplantation market forecast, Hodgkin lymphoma is considered a very prominent indication and will occupy significant shares from 2022 to 2030. In addition to that, acute leukemia is trending in the bone marrow transplant industry due to the increasing number of cases of this indication. Furthermore, solid tumors are likely to record a substantial growth rate during the projected timeframe from 2022 to 2030.
Bone Marrow Transplantation Market By End-User
As per our findings, the hospitals sub-segment generated the largest market revenue in 2021 and is expected to do so in the coming years. The presence of advanced medical infrastructure, the presence of expert healthcare professionals, and the growing prevalence of cancer and anemia are the factors that are supporting the hospital segment. A bone marrow transplant is indicated to treat advanced stages of blood cancer, sickle cell anemia, and other chronic disorders.
Bone Marrow Transplantation Market Regional Outlook
The Middle East & Africa (MEA)
Introduction to Innovative Healthcare Systems in European Countries Boost the Europe Bone Marrow Transplantation Market
Europe is expected to remain at its highest position as compared to other geographies, accounting for 60% of the global market share. North America is the second largest region followed by Europe. The bone marrow industry would allow the area to thrive on factors such as rising cases of chronic diseases, such as blood cancer, coupled with growing aging populations. Asia-Pacific demand for successful bone marrow transplantation may not be as high as the European and North American industries, which will also become an important medical tourism sector.
Bone Marrow Transplantation Market Players
Some of the top bone marrow transplantation companies offered in the professional report include Agendia, Merck Millipore Corporation, Sanofi, AllCells LLC, Diadexus Inc., Abbott, STEMCELL Technologies, Lonza Group Ltd., Conversant Bio, and Qiagen N.V.
The market size of bone marrow transplantation market in 2021 was accounted to be USD 11,108 Million.
The projected CAGR of bone marrow transplantation market during the analysis period of 2022 to 2030 is 5.7%.
The prominent players of the global bone marrow transplantation market are Agendia, Merck Millipore Corporation, Sanofi, AllCells LLC, Diadexus Inc., Abbott, STEMCELL Technologies, Lonza Group Ltd., Conversant Bio, and Qiagen N.V.
North America held the dominating bone marrow transplantation during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for bone marrow transplantation during the analysis period of 2022 to 2030.
Growing clinical trials for cell therapy, growing prevalence of blood cancer across the world, and increasing number of surgical procedures drives the growth of global bone marrow transplantation market.
Based on type, analogous bone marrow transplant segment is expected to hold the maximum share bone marrow transplantation market.